Source: StreetInsider

Press Release: Qu Biologics : Qu Biologics' Immunomodulator Clears Senescence

BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific...

Read full article »
Qu Biologics's Competitors | Qu Biologics's News | Qu Biologics's Financials
Stay up-to-date with the latest news on Qu Biologics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Hal Gunn's photo - Founder & CEO of Qu Biologics

Founder & CEO

Hal Gunn

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on Qu Biologics